As shown in Figure 1, IFN-γ and GzB production was comparable, but CD8+ T cells from MS patients produced significantly lower amounts of IL-2 (P = 0.0105) and PFN (P = 0.0077) in comparison to HCs upon stimulation with CERI peptides. The gene discussed is IL2; the disease is myeloid sarcoma.